Kiniksa Pharmaceuticals International (KNSA) Earnings Date & Reports

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

KNSA is expected to report earnings to rise 12.67% to 30 cents per share on July 28

Kiniksa Pharmaceuticals International KNSA Stock Earnings Reports

Q2'26

Est.

$0.30

Q1'26

Beat

by $0.06

Q4'25

Missed

by $0.18

Q3'25

Missed

by $0.09

Q2'25

Beat

by $0.04

The last earnings report on April 28 showed earnings per share of 27 cents, beating the estimate of 20 cents. With 6.76M shares outstanding, the current market capitalization sits at 4.92B.

View a ticker or compare two or three

Compare

KNSA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for KNSA